1 Result(s)

Article

Comparative Economics of a 12-Gene Assay for Predicting Risk of Recurrence in Stage II Colon Cancer

Prior economic analysis that compared the 12-gene assay to published patterns of care predicted the assay would improve outcomes while lowering medical costs for stage II, T3, mismatch-repair-proficient (MMR-P...

Steven R. Alberts, Tiffany M. Yu, Robert J. Behrens, Lindsay A. Renfro… in PharmacoEconomics (2014)